Vanda Pharmaceuticals Urges FDA to Revise Draft Guidance on New Approach Methodologies
2026-05-27
PubComNonGov2026-05-27
Carter Struck
WASHINGTON, May 27 -- Vanda Pharmaceuticals Inc., a global biopharmaceutical company known for developing innovative therapies for rare disorders, has submitted a public comment letter to the U.S. Foo . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 27 -- Vanda Pharmaceuticals Inc., a global biopharmaceutical company known for developing innovative therapies for rare disorders, has submitted a public comment letter to the U.S. Foo . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026